Cystic fibrosis (CF) research and case reports were robust in the year 2018. This report
summarizes publications related the multisystem effects of CF, pulmonary exacerbations …

Cystic fibrosis research and case reports were robust in the year 2018. This report
summarizes research and cases related to Cystic Fibrosis Transmembrane Conductance …

During the year 2019, research and case reports/series in the field of cystic fibrosis (CF)
were in abundance. To adequately address the large body of CF research published during …

Remarkable medical advancements have been made for people with cystic fibrosis (CF) in
recent years, with an abundance of research continuing to be conducted worldwide. With …

People with cystic fibrosis (CF) have an amazing outlook with the treatment availability of
highly effective modulators. Unfortunately, not all people with CF are eligible for modulators …

This past year, there were many important advances for patients with cystic fibrosis (CF). Of
the many publications related to CF in 2023, there was further evaluation of highly effective …

The evidence base for modulator therapies in cystic fibrosis (CF) has continued to expand,
and it is likely that up to 90% of people with CF could benefit. Worldwide there are however …

Introduction: Cystic fibrosis (CF) outcomes and survival have improved over the last century
primarily due to advancements in antibiotics, nutritional, and pulmonary therapies …

The outlook for those with cystic fibrosis (CF) has never been brighter with ever increasing
life expectancy and the approval of the highly effective CFTR modulators, such as …

ABSTRACT The 31st annual North American Cystic Fibrosis Conference (NACFC) was held
in Indianapolis, IN on November 2–4, 2017. Abstracts of presentations from the conference …